Is BOP1 p.Val602Ile (c.1804G>A) pathogenic?

BOP1 p.Val602Ile (c.1804G>A) is classified Uncertain significance in BOP1 (ClinVar, Single submitter, 1 submitter; last evaluated 2021-09-17). AlphaMissense: likely benign (0.0613); Rare (popmax 0.134%, sas).

How common is BOP1 p.Val602Ile (c.1804G>A) in the general population?

BOP1 p.Val602Ile (c.1804G>A) is rare (popmax 0.134%, sas) (gnomAD).

What do computational predictors say about BOP1 p.Val602Ile (c.1804G>A)?

AlphaMissense predicts likely benign (score 0.0613) — an in-silico prediction, not a clinical call.

BOP1 p.Val602Ile

c.1804G>A · rs781924844 · VCV2250996

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0613 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.134%, sas)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0613	likely benign
REVEL	0.024	moderately benign-leaning
SaProt	LLR -5.64	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -4.6	GERP -2.9
Regional constraint	o/e 1.09	unconstrained · MANE · 29 kb · p 0.0028 · regional, not allelic
Overall
CADD	8.99	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.134% South Asian · 114/84,958 alleles

Filtering AF 0.114% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.107%

Overall 0.00931% 144/1,547,258 alleles · rare

Ancestry group	Frequency	1 in
South Asiangrpmax	0.134%	745
Remaining individualsnot grpmax-eligible	0.0116%	8,609
African / African-American	0.00813%	12,294
Ashkenazi Jewishnot grpmax-eligible	0.00348%	28,710
European (non-Finnish)	0.00139%	72,057

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: BOP1
Protein: p.Val602Ile
Coding: c.1804G>A
MANE Select: NM_015201
dbSNP: rs781924844
Type: single nucleotide variant
Location: chr8:144262943 (GRCh38)
Gene constraint: LOEUF 0.913 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 80.32 · 10 PDB
Residue 602: a β-strand

Full BOP1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

BOP1 p.Ala7Val Uncertain significance ★ ⚠ same type
BOP1 p.Arg20Trp Uncertain significance ★ ⚠ same type
BOP1 p.Arg21Gln Uncertain significance ★ ⚠ same type
BOP1 p.Arg568Cys Uncertain significance ★ ⚠ same type
BOP1 p.Arg576Cys Uncertain significance ★ ⚠ same type
BOP1 p.Arg576His Uncertain significance ★ ⚠ same type
BOP1 p.Arg577His Uncertain significance ★ ⚠ same type
BOP1 p.Arg591Gln Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bop1-p-val602ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown